{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:13:13Z","timestamp":1769202793301,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.2353\/jmoldx.2009.080048","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T00:54:59Z","timestamp":1238115299000},"page":"201-210","source":"Crossref","is-referenced-by-count":20,"title":["Sensitive and Specific Measurement of Minimal Residual Disease in Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"11","author":[{"given":"Alexander A.","family":"Morley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Latham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Brisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Wilczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Budgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"van Zanten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryone J.","family":"Kuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola C.","family":"Venn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray D.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Crock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Storey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/jmoldx.2009.080048_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(94)90988-1","article-title":"Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction","volume":"343","author":"Brisco","year":"1994","journal-title":"Lancet"},{"key":"10.2353\/jmoldx.2009.080048_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer\u2013Childhood Leukemia Cooperative Group","volume":"339","author":"Cave","year":"1998","journal-title":"N Engl J Med"},{"key":"10.2353\/jmoldx.2009.080048_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","article-title":"Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia","volume":"351","author":"Coustan-Smith","year":"1998","journal-title":"Lancet"},{"key":"10.2353\/jmoldx.2009.080048_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.2353\/jmoldx.2009.080048_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2353\/jmoldx.2009.080047","article-title":"Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemia","volume":"11","author":"Brisco","year":"2009","journal-title":"J Mol Diagn"},{"key":"10.2353\/jmoldx.2009.080048_bib6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"European Study Group on MRDdiALL: Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080048_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-9994-3-11","article-title":"Quantification of damage in DNA recovered from highly degraded samples: a case study of DNA in faeces","volume":"3","author":"Deagle","year":"2006","journal-title":"Frontiers Zool"},{"key":"10.2353\/jmoldx.2009.080048_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","article-title":"Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects","volume":"17","author":"van der Velden","year":"2003","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080048_bib9","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/leu.2008.121","article-title":"Improving minimal residual disease testing in precursor-B-ALL based on immunoglobulin kappa and heavy chain gene rearrangements","volume":"22","author":"Sutton","year":"2008","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080048_bib10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.leu.2404535","article-title":"Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080048_bib11","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.1992.10.12.1879","article-title":"Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia","volume":"10","author":"Wasserman","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.2353\/jmoldx.2009.080048_bib12","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood.V95.8.2651","article-title":"Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia","volume":"95","author":"Donovan","year":"2000","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080048_bib13","first-page":"3281","article-title":"Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology","volume":"60","author":"Nakao","year":"2000","journal-title":"Cancer Res"},{"key":"10.2353\/jmoldx.2009.080048_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.leu.2404925","article-title":"Non-specific amplification of patient-specific Ig\/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring","volume":"22","author":"van der Velden","year":"2008","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080048_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2141.2006.06056.x","article-title":"Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia","volume":"133","author":"van der Velden","year":"2006","journal-title":"Br J Haematol"},{"key":"10.2353\/jmoldx.2009.080048_bib16","first-page":"2284","article-title":"Improved measurement of minimal residual disease (MRD)","volume":"108","author":"Morley","year":"2006","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.2353\/jmoldx.2009.080048_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2141.1997.3723186.x","article-title":"Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia","volume":"99","author":"Brisco","year":"1997","journal-title":"Br J Haematol"},{"key":"10.2353\/jmoldx.2009.080048_bib18","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood-2002-04-1130","article-title":"Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia","volume":"100","author":"Coustan-Smith","year":"2002","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080048_bib19","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1182\/blood-2003-05-1455","article-title":"Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection","volume":"102","author":"Li","year":"2003","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080048_bib20","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V99.7.2315","article-title":"Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease","volume":"99","author":"Szczepanski","year":"2002","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080048_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.leu.2401970","article-title":"Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy","volume":"15","author":"de Haas","year":"2001","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080048_bib22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2007-01-067785","article-title":"Relapse in children with acute lymphoblastic leukemia involving selection of a pre-existing drug-resistant subclone","volume":"110","author":"Choi","year":"2007","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080048_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/leu.2008.5","article-title":"International BFM Study Group (I-BFM-SG) (2008) Minimal residual disease (MRD)-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (ALL)","volume":"22","author":"Flohr","year":"2008","journal-title":"Leukemia"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810602292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810602292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T03:47:31Z","timestamp":1589687251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157810602292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1525157810602292"],"URL":"https:\/\/doi.org\/10.2353\/jmoldx.2009.080048","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}